Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants EUA for Lilly and Incyte’s baricitinib for Covid-19 treatment

pharmaceutical-technologyNovember 23, 2020

Tag: FDA , Baricitinib , Eli Lilly , Incyte , COVID-19

PharmaSources Customer Service